Home › NDC Lookup › RxCUI directory › RxCUI 2686633

2 ML crovalimab-akkz 170 MG/ML Injection [Piasky] — RxCUI 2686633

Name: 2 ML crovalimab-akkz 170 MG/ML Injection [Piasky] (RxCUI 2686633)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2686633 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2686633

Official name2 ML crovalimab-akkz 170 MG/ML Injection [Piasky]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as2 ML Piasky 170 MG/ML Injection; Piasky 340 MG in 2 ML Injection; Piasky 340 MG per 2 ML Injection

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 2 ML crovalimab-akkz 170 MG/ML Injection [Piasky... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML crovalimab-akkz 170 MG/ML Injection [Piasky] RxCUI 2686633 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Crovalimab 2686619 IN
- Crovalimab-akkz 2686620 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Piasky 2686628 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Crovalimab Injection 2686623 SCDF
- Crovalimab-akkz Injection 2686625 SCDFP
- Crovalimab Injectable Product 2686622 SCDG
- Crovalimab-akkz Injectable Product 2686624 SCDGP
- Crovalimab Injection [Piasky] 2686631 SBDF
- Crovalimab-akkz Injection [Piasky] 2686632 SBDFP
- Piasky Injectable Product 2686630 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 2 ML crovalimab-akkz 170 MG/ML Injection 2686626 SCD
- Crovalimab-akkz 170 MG/ML 2686621 SCDC
- Crovalimab-akkz 170 MG/ML [Piasky] 2686629 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

2 ML crovalimab-akkz 170 MG/ML Injection SCD · 2686626
Crovalimab-akkz 170 MG/ML SCDC · 2686621
Crovalimab Injection SCDF · 2686623
Crovalimab-akkz Injection SCDFP · 2686625
Crovalimab Injectable Product SCDG · 2686622
Crovalimab-akkz Injectable Product SCDGP · 2686624

Brand-Name Concepts

Crovalimab-akkz 170 MG/ML [Piasky] SBDC · 2686629
Crovalimab Injection [Piasky] SBDF · 2686631
Crovalimab-akkz Injection [Piasky] SBDFP · 2686632
Piasky Injectable Product SBDG · 2686630
Piasky BN · 2686628

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2686633 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50242-0115-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-115-01) / 2 mL in 1 V...	Piasky	Genentech, Inc.	2024-06-20

Observed labelers: Genentech, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1307	Inj, crovalimab-akkz, 10 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.